SS Innovations, a developer of innovative surgical robotic technologies, has submitted a 510(k) premarket notification to the US Food and Drug Administration for the SSI Mantra surgical robotic system for multiple specialty procedure types, including: general, urological, colorectal, gynecological, and cardiac surgery.
Dr Sudhir Srivastava, chairman CEO of SS Innovations, says: “Our submission of a 510(k) premarket notification to the FDA marks an important milestone in our strategic plan to introduce the Company’s advanced, cost-efficient SSi Mantra surgical robotic system to the US market.
“Given its affordability, differentiated technology, and proven performance across our existing global installations, we believe the SSi Mantra represents a highly compelling option for hospitals and surgeons in the United States, especially those serving underserved patient communities.” [Read more…] about SS Innovations applies for FDA approval for its Mantra robotic surgical system